- Kovac, Victor;
- Shapiro, Elsa G;
- Rudser, Kyle D;
- Mueller, Bryon A;
- Eisengart, Julie B;
- Delaney, Kathleen A;
- Ahmed, Alia;
- King, Kelly E;
- Yund, Brianna D;
- Cowan, Morton J;
- Raiman, Julian;
- Mamak, Eva G;
- Harmatz, Paul R;
- Shankar, Suma P;
- Ali, Nadia;
- Cagle, Stephanie R;
- Wozniak, Jeffrey R;
- Lim, Kelvin O;
- Orchard, Paul J;
- Whitley, Chester B;
- Nestrasil, Igor
Objective
To assess our hypothesis that brain macrostructure is different in individuals with mucopolysaccharidosis type I (MPS I) and healthy controls (HC), we conducted a comprehensive multicenter study using a uniform quantitative magnetic resonance imaging (qMRI) protocol, with analyses that account for the effects of disease phenotype, age, and cognition.Methods
Brain MRIs in 23 individuals with attenuated (MPS IA) and 38 with severe MPS I (MPS IH), aged 4-25 years, enrolled under the study protocol NCT01870375, were compared to 98 healthy controls.Results
Cortical and subcortical gray matter, white matter, corpus callosum, ventricular and choroid plexus volumes in MPS I significantly differed from HC. Thicker cortex, lower white matter and corpus callosum volumes were already present at the youngest MPS I participants aged 4-5 years. Age-related differences were observed in both MPS I groups, but most markedly in MPS IH, particularly in cortical gray matter metrics. IQ scores were inversely associated with ventricular volume in both MPS I groups and were positively associated with cortical thickness only in MPS IA.Conclusions
Quantitatively-derived MRI measures distinguished MPS I participants from HC as well as severe from attenuated forms. Age-related neurodevelopmental trajectories in both MPS I forms differed from HC. The extent to which brain structure is altered by disease, potentially spared by treatment, and how it relates to neurocognitive dysfunction needs further exploration.